Precision Neuroscience

Precision Neuroscience is a New York-based neurotechnology company developing minimally invasive brain-computer interfaces to restore communication and motor function in patients with paralysis and neurological conditions. The company's flagship product is the Layer 7 Cortical Interface, a thin-film electrode array designed for rapid surgical placement directly on the brain's surface. Unlike traditional neural implants that require penetrating electrodes, Precision Neuroscience's approach prioritizes accessibility and safety through a less invasive methodology that can be deployed more quickly and with reduced surgical complexity.

The company has established itself as a significant player in the competitive BCI space, having raised $93 million in Series C funding that demonstrates strong investor confidence in its technology and clinical potential. Precision Neuroscience is advancing toward human clinical trials, positioning itself among the leading contenders in translating brain-computer interface technology from the laboratory into therapeutic applications for patients in need. The company's progress reflects a broader industry momentum toward practical, clinically viable solutions that can meaningfully improve quality of life for people living with severe paralysis.

Precision Neuroscience addresses a critical gap in the neurotech industry by offering a scalable alternative to highly invasive neural recording systems that have traditionally limited BCI adoption. The Layer 7 platform's non-penetrating design could democratize access to brain-computer interface therapy by reducing surgical barriers, complications, and recovery time compared to existing approaches. By advancing minimally invasive technology toward clinical reality, Precision Neuroscience is helping reshape expectations for what is possible in neural restoration and is contributing to the industry's evolution toward safer, more accessible neurotech solutions.